Ardent Health Inc (ARDT) Hedge Fund Ownership (Q2 2026)

Q: Is it too late to buy Ardent Health Inc (ARDT) following the 2026 Q2 hedge fund 13F filings?

As of today, ARDT has moved +0.8% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.2% for the XLV sector ETF — an outperformance of +0.6%. Since the quarter end (June 30, 2026), ARDT gained +11.8% vs +5.7% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Ardent Health Inc (ARDT)

136 + Investors. Track Smart Money conviction in ARDT. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — ARDT

Based on 137 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 4 quarters in a row

last 6Q

For 4 consecutive quarters, more hedge funds added ARDT than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🏔️

At the ownership peak (100% of max)

100% of all-time peak

137 hedge funds hold ARDT right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

🚀

Fast accumulation — +27% more funds vs a year ago

fund count last 6Q

+29 new funds entered over the past year (+27% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.

🟢

More buyers than sellers — 61% buying

89 buying56 selling

Last quarter: 89 funds were net buyers (25 opened a brand new position + 64 added to an existing one). Only 56 were sellers (35 trimmed + 21 sold completely). A clear majority buying is a strong confirmation signal.

➡️

Steady new buyers — ~25 new funds per quarter

new funds entering per quarter

Funds opening this position for the first time: 36 → 34 → 30 → 25. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.

🔄

Mostly new holders — 32% entered in last year

■ 5% conviction (2yr+) ■ 63% medium ■ 32% new

Only 7 funds (5%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

💰

Value +18% but shares only +2% — price-driven

Value

+17%

+2%

Last quarter: the total dollar value of institutional holdings rose +18%, but actual share count only changed +2%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.

📊

Peak discovery — momentum slowing

19 → 36 → 34 → 30 → 25 new funds/Q

New funds entering each quarter: 36 → 34 → 30 → 25. ARDT is well-known in the hedge fund world, but fresh entries are gradually declining. The explosive phase of institutional discovery is likely behind us.

📊

Mixed cohorts — 4% veterans, 44% new entrants

■ 4% veterans ■ 53% 1-2yr ■ 44% new

Of 139 current holders: 5 (4%) held 2+ years, 73 held 1–2 years, 61 (44%) entered in the past year. Balanced distribution — some institutional memory, some recent momentum buyers.

📋

Smaller funds dominant — 11% AUM from top-100

11% from top-100 AUM funds

42 of 137 holders rank in the top 100 by AUM, but together hold only 11% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

4.1

out of 10

Moderate Exit Risk

Exit risk score 4.1/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q2)	Prior (2026 Q1)	Change
Funds Holding	136	133	2.26%
13F Shares	109M	106M	2.39%
Total Value	$1.06B	$904M	17.59%
New Positions	25	30	-5
Increased Positions	64	49	+15
Closed Positions	22	22	-
Reduced Positions	33	36	-3
Total Calls	1	0	100%
Total Puts	1	0	100%
PUT/CALL Ratio	1.0	0.0	Neutral

Metric

All 13F Filers (2026 Q2)

Prior (2026 Q1)

Change

Funds Holding

136

133

2.26%

13F Shares

109M

106M

2.39%

Total Value

$1.06B

$904M

17.59%

New Positions

-5

Increased Positions

+15

Closed Positions

Reduced Positions

-3

Total Calls

100%

Total Puts

100%

PUT/CALL Ratio

1.0

0.0

Neutral

Institutional Holders (2026 Q2)

136 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in ARDT. Verified SEC 13F-HR filings.

QUARTER:

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 ARDT holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Ventas, Inc.	100.00%	9,342,501	$91.9M
2	Chai Trust Co LLC	52.26%	77,246,499	$760.1M
3	Goldentree Asset Management LP	0.90%	1,580,423	$15.5M
4	Denali Advisors LLC	0.23%	236,250	$2.3M
5	SageView Advisory Group, LLC	0.20%	640,596	$5.5M
6	Bridgeway Capital Management, LLC	0.15%	841,126	$8.3M
7	CastleKnight Management LP	0.14%	1,076,967	$10.6M
8	VARCOV Co.	0.13%	36,015	$354K
9	Prescott Group Capital Management, L.L.C.	0.10%	121,925	$1.2M
10	Monetary Solutions, Ltd	0.08%	8,972	$88K
11	Algert Global LLC	0.07%	597,745	$5.9M
12	R Squared Ltd	0.06%	12,193	$120K
13	Wedge Capital Management L L P/Nc	0.05%	327,242	$3.2M
14	Mangrove Partners IM, LLC	0.05%	81,911	$806K
15	Empowered Funds, LLC	0.03%	551,293	$5.4M
16	Axq Capital, LP	0.03%	25,045	$246K
17	Mirabella Financial Services LLP	0.03%	27,574	$271K
18	Prelude Capital Management, LLC	0.03%	35,330	$348K
19	State of Wyoming	0.02%	22,199	$218K
20	Fox Run Management, L.L.C.	0.02%	10,813	$106K
21	Abel Hall, LLC	0.02%	10,196	$100K
22	Martingale Asset Management L P	0.01%	61,818	$608K
23	Susquehanna Portfolio Strategies, LLC	0.01%	87,885	$865K
24	Hotchkis & Wiley Capital Management LLC	0.01%	444,896	$4.4M
25	Lbmc Investment Advisors, LLC	0.01%	10,000	$98K

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Ardent Health Inc (ARDT)

What does the Smart Money Trend signal show for ARDT?

Buying streak — 4 quarters in a row: For 4 consecutive quarters, more hedge funds added ARDT than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for ARDT?

More buyers than sellers — 61% buying: Last quarter: 89 funds were net buyers (25 opened a brand new position + 64 added to an existing one). Only 56 were sellers (35 trimmed + 21 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for ARDT holders?

Smaller funds dominant — 11% AUM from top-100: 42 of 137 holders rank in the top 100 by AUM, but together hold only 11% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held ARDT?

Mostly new holders — 32% entered in last year: Only 7 funds (5%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Is it too late to buy Ardent Health Inc (ARDT) following the 2026 Q2 hedge fund 13F filings?

As of today, ARDT has moved +0.8% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.2% for the XLV sector ETF — an outperformance of +0.6%. Since the quarter end (June 30, 2026), ARDT has gained +11.8% vs +5.7% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Ardent Health Inc (ARDT)

Smart Money Signals — ARDT

Buying streak — 4 quarters in a row

At the ownership peak (100% of max)

Fast accumulation — +27% more funds vs a year ago

More buyers than sellers — 61% buying

Steady new buyers — ~25 new funds per quarter

Mostly new holders — 32% entered in last year

Value +18% but shares only +2% — price-driven

Peak discovery — momentum slowing

Mixed cohorts — 4% veterans, 44% new entrants

Smaller funds dominant — 11% AUM from top-100

Institutional Sentiment Summary — ARDT

Hedge Fund Ownership: ARDT

Market Analysis: ARDT

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: ARDT

Is It Too Late to Buy Ardent Health Inc (ARDT) Based on Hedge Fund 13F Filings?

Hedge Fund Positioning: ARDT

Statistics: ARDT

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q2)

Frequently Asked Questions — Ardent Health Inc (ARDT)

Welcome to 13Foresight!